Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban

Por Frost, Charles E., Song, Yan, Shenker, Andrew, Wang, Jessie, Barrett, Yu Chen, Schuster, Alan, Harris, Stuart I., LaCreta, Frank
Publicado no Clin Pharmacokinet (2015)

Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

Por Upreti, Vijay V, Song, Yan, Wang, Jessie, Byon, Wonkyung, Boyd, Rebecca A, Pursley, Janice M, LaCreta, Frank, Frost, Charles E
Publicado em 2013

Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects

Por Upreti, Vijay V, Wang, Jessie, Barrett, Yu Chen, Byon, Wonkyung, Boyd, Rebecca A, Pursley, Janice, LaCreta, Frank P, Frost, Charles E
Publicado em 2013

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

Por Frost, Charles E, Byon, Wonkyung, Song, Yan, Wang, Jessie, Schuster, Alan E, Boyd, Rebecca A, Zhang, Donglu, Yu, Zhigang, Dias, Clapton, Shenker, Andrew, LaCreta, Frank
Publicado no Br J Clin Pharmacol (2015)

First‐in‐human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS‐962212, a direct, reversible, small molecule factor XIa inhibitor in non‐Japanese and Japane...

Por Perera, Vidya, Luettgen, Joseph M., Wang, Zhaoqing, Frost, Charles E., Yones, Cynthia, Russo, Cesare, Lee, John, Zhao, Yue, LaCreta, Frank P., Ma, Xuewen, Knabb, Robert M., Seiffert, Dietmar, DeSouza, Mary, Mugnier, Pierre, Cirincione, Brenda, Ueno, Takayo, Frost, Robert J. A.
Publicado no Br J Clin Pharmacol (2018)